Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".
作者信息
Bai Ying, Shantsila Alena, Lip Gregory Y H
机构信息
Institute of Cardiovascular Sciences University of Birmingham, Birmingham, United Kingdom.